• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨Paget病中骨转换的生化标志物。

Biochemical markers of bone turnover in Paget's disease of bone.

作者信息

Delmas P D

机构信息

INSERM Research Unit 403 and Claude Bernard University of Lyon, Lyon, France.

出版信息

J Bone Miner Res. 1999 Oct;14 Suppl 2:66-9. doi: 10.1002/jbmr.5650140213.

DOI:10.1002/jbmr.5650140213
PMID:10510216
Abstract

Although the measurement of total alkaline phosphatase activity in serum is a valid index to assess the activity of Paget's disease of bone and to monitor treatment efficacy, this marker may lack sensitivity in some cases. Among the various markers of bone formation and resorption that have been developed, serum bone specific alkaline phosphatase and procollagen I N-terminal peptide (PINP) for formation, urinary N-telopeptide (NTX) and alpha-C-telopeptide (CTX) for bone resorption have emerged as the most sensitive ones, and may be useful in the management of pagetic patients. We have recently shown that the beta-isomerization of type I collagen CTX is impaired in pagetic bone matrix characterized by the existence of woven bone, as compared to normal lamellar bone matrix. This abnormality results in a preferential urinary excretion of nonisomerized (alpha-CTX) over beta-isomerized (beta-CTX) that can be measured with specific immunoassays. Patients with active Paget's disease of bone are characterized by an abnormally high alpha/beta-CTX ratio which goes down to the normal range after bisphosphonate therapy, probably reflecting the lamellar structure of newly formed bone matrix in pagetic skeletal sites after treatment.

摘要

虽然血清中总碱性磷酸酶活性的测定是评估骨Paget病活性及监测治疗效果的有效指标,但该标志物在某些情况下可能缺乏敏感性。在已开发的各种骨形成和骨吸收标志物中,用于骨形成的血清骨特异性碱性磷酸酶和I型前胶原N端肽(PINP),以及用于骨吸收的尿N端肽(NTX)和α-C端肽(CTX)已成为最敏感的标志物,可能有助于Paget病患者的管理。我们最近发现,与正常板层骨基质相比,以编织骨存在为特征的Paget病骨基质中I型胶原CTX的β异构化受损。这种异常导致非异构化(α-CTX)比β异构化(β-CTX)更优先经尿液排泄,这可以通过特异性免疫测定法进行测量。活动性骨Paget病患者的特征是α/β-CTX比值异常高,双膦酸盐治疗后该比值降至正常范围,这可能反映了治疗后Paget病骨骼部位新形成骨基质的板层结构。

相似文献

1
Biochemical markers of bone turnover in Paget's disease of bone.骨Paget病中骨转换的生化标志物。
J Bone Miner Res. 1999 Oct;14 Suppl 2:66-9. doi: 10.1002/jbmr.5650140213.
2
Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.测量I型胶原降解产物的非异构化和β-异构化形式的尿排泄量,以监测双膦酸盐唑来膦酸在佩吉特病中的作用。
Arthritis Rheum. 1998 Feb;41(2):354-60. doi: 10.1002/1529-0131(199802)41:2<354::AID-ART20>3.0.CO;2-5.
3
Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.骨Paget病中I型胶原α1链C末端端肽的β-异构化减少。
J Bone Miner Res. 1997 Sep;12(9):1407-15. doi: 10.1359/jbmr.1997.12.9.1407.
4
Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.非异构化C-端肽片段是监测骨Paget病疾病活动和治疗效果的高度敏感标志物。
J Bone Miner Res. 2005 Apr;20(4):588-95. doi: 10.1359/JBMR.041212. Epub 2004 Dec 6.
5
Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease.骨转换生化标志物在评估佩吉特病治疗反应中的应用价值。
Bone. 2001 Nov;29(5):447-52. doi: 10.1016/s8756-3282(01)00592-0.
6
Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.在评估佩吉特病活动度时骨转换生化标志物与骨闪烁显像指标之间的关系。
Arthritis Rheum. 1997 Mar;40(3):461-8. doi: 10.1002/art.1780400312.
7
Effect of surgical menopause and Paget's disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: evolution after antiresorptive therapy.手术绝经和骨佩吉特病对I型胶原羧基末端肽异构化的影响:抗吸收治疗后的演变
J Bone Miner Metab. 2002;20(2):116-20. doi: 10.1007/s007740200016.
8
Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.骨闪烁显像在评估佩吉特病活动度中的定量评估
Nucl Med Commun. 1999 Jun;20(6):525-8. doi: 10.1097/00006231-199906000-00006.
9
Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.骨转换生化标志物在评估佩吉特病活动度中的鉴别价值。
J Bone Miner Res. 1995 Mar;10(3):458-65. doi: 10.1002/jbmr.5650100318.
10
Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.骨Paget病双膦酸盐治疗后的长期生化反应。建议的治疗监测间隔时间。
Rheumatology (Oxford). 2004 Jul;43(7):869-74. doi: 10.1093/rheumatology/keh185. Epub 2004 Mar 30.

引用本文的文献

1
Alkaline phosphatase and acid phosphatase in health and disease - A systematic review.健康与疾病中的碱性磷酸酶和酸性磷酸酶——一项系统综述
J Oral Maxillofac Pathol. 2025 Apr-Jun;29(2):324-334. doi: 10.4103/jomfp.jomfp_304_24. Epub 2025 Jun 30.
2
The Superiority of Zoledronic Acid Over Risedronate for Paget's Disease: A 16-Year Experience at a Single Institution.唑来膦酸对比利塞膦酸钠治疗佩吉特病的优势:一家机构16年的经验
Cureus. 2022 Dec 25;14(12):e32923. doi: 10.7759/cureus.32923. eCollection 2022 Dec.
3
Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review.
绝经后骨质疏松症药物治疗中生物标志物的潜力:系统评价。
J Orthop Surg Res. 2021 May 31;16(1):351. doi: 10.1186/s13018-021-02497-0.
4
Functional investigation of bone implant viability using radiotracers in a new model of osteonecrosis.在一种新的骨坏死模型中使用放射性示踪剂对骨植入物活力进行功能研究。
Clinics (Sao Paulo). 2016 Oct 1;71(10):617-625. doi: 10.6061/clinics/2016(10)11.
5
Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.骨Paget病中的骨转换标志物:一项系统评价和荟萃分析。
Osteoporos Int. 2015 Jul;26(7):1875-91. doi: 10.1007/s00198-015-3095-0. Epub 2015 Jun 3.
6
Osteogenic scaffolds for bone reconstruction.用于骨重建的成骨支架
Biores Open Access. 2012 Jun;1(3):137-44. doi: 10.1089/biores.2012.0226.
7
Recent advances in the use of serological bone formation markers to monitor callus development and fracture healing.使用血清学骨形成标志物监测骨痂发育和骨折愈合的最新进展。
Crit Rev Eukaryot Gene Expr. 2010;20(2):105-27. doi: 10.1615/critreveukargeneexpr.v20.i2.20.
8
Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip.髋关节快速破坏性骨关节炎患者血清I型胶原C末端肽水平升高。
Int Orthop. 2005 Feb;29(1):1-5. doi: 10.1007/s00264-004-0608-4. Epub 2004 Dec 30.